During the 2018 DIA conference: 25-27th of June in Boston, MA, PRA conducted a survey for those who stopped by our booth, gathering feedback on participants’ opinions on drug development, as well as its effect on patients. The survey totaled five questions—four multiple choice and one open-ended question. This report covers the feedback we received on these questions from 453 attendees